The report will be delivered in 2-3 business days.

Pediatric Vaccines Market Global Report 2020-30: Covid 19 Impact and Recovery

Starting Price : $ 4000.00 $3200.00 | Pages : 150 | Published : April 2020 | SKU CODE : 7640 | Format :


The pediatric vaccines market consists of sales of pediatric vaccines and its related services used to provide immunity to infants and children for specific diseases. Pediatric vaccine is a preparation of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or several diseases among children. Pediatric vaccines are used in childhood immunization schedules to enhance a child’s immunity or prevent diseases such as diphtheria, tetanus, pertussis, influenza, Hepatitis B, polio and many other infectious and non-infectious diseases.

The global pediatric vaccines is expected to decline from $30.4 billion in 2019 to $28.9 billion in 2020 at a compound annual growth rate (CAGR) of -5%. The decline is mainly due to the focus on Covid-19 outbreak and its treatment across the globe and non-availability of vaccines or delay of immunizations in pediatrics. The market will stabilize or grow from next year owing to the easing of supply chain restrictions. Also, successful launch of the covid19 vaccine or immunization of existing BCG vaccine in countries where it is not administered at present, which will boost the pediatric vaccines market significantly in the mid to long term. The market is expected to recover and reach $40.7 billion in 2023 at a CAGR of 7.8%.

The pediatric vaccines market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. North America was the largest region in 2019. Asia Pacific was the fastest region during the period 2019-2025.

The pediatric vaccines market covered in this report is segmented by vaccine type into monovalent, multivalent and by technology into live attenuated, inactivated, toxoid, conjugate, and other technologies.

Rising prevalence of chronic diseases such as tuberculosis, diphtheria, and pneumonia in the age group of 15 years and below will contribute to the growth of the pediatric vaccines market. The risk of severe disease outcomes and complications of infectious diseases are increasing in children and adolescents with chronic conditions. As stated by centers for disease control and prevention, the prevalence of obesity was 18.5% in the US and about 13.7 million children and adolescents were affected by obesity in 2015. The increased prevalence of chronic diseases among children rises the demand for immunization from chronic diseases, hence, driving the pediatric vaccines market’s growth.

Vaccine refusal by parents for their children is a prevailing tradition in many countries. Among the reasons for withholding children for vaccination are lack of knowledge, religious and philosophical objections, exaggerated concerns regarding vaccine safety and others. According to a report published by CNBC, the US national refusal rate of parents for a child’s immunization was 3.3% in 2018. Governments are imposing laws and organizing awareness programs to overcome parent’s and family’s resistance to the child’s vaccine, but are unable to impose any strict rules against parents’ refusal for children’s immunization, which is hindering the pediatric vaccines market’s growth.

The demand for novel vaccines is steadily growing to deliver improved immunization against challenging infectious diseases (e.g. tuberculosis, HIV/ AIDS) and non-communicable chronic diseases such as cancer and neurodegenerative diseases. Novel approaches to vaccine development include structural immunogenic design, gene-based vaccine platforms, and effective adjuvant recombinant antigen formulations. To meet the increasing demand for novel vaccines, there is a continuous quest in pediatric vaccine manufacturers and developers for innovation of vaccine design and manufacturing technologies. For instance, in January 2020, Hilleman laboratories, a global research, and development organization, has announced their plans to develop a novel vaccine against Group B Streptococcus, a major cause for neonatal infections in women, into the area of maternal and child health.  

The major players in the global pediatric vaccines market are GlaxoSmithKline plc, Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Indian Immunologicals Limited, AstraZeneca plc, CSL Limited, Mitsubishi Tanabe Pharma Corporation, Serum Institute of India Pvt. Ltd., Panacea Biotec Ltd., Zydus Cadila, BIO-MED, Squibb, Novartis , Abbott Laboratries, Eli Lillyand Company, F. Hoffmann- La Roche Ltd., Novo Nordisk A/S, VF Corporation, Sinovac Biotech Ltd., Bristol- Myers, Sun Pharmaceutical Industries Ltd, Sellas and Takeda Pharmaceutical Company Limited, Daiichi Sankyo, Bristol- Myers, Sinovac Biotec Ltd., , , , ,

The countries covered in the global pediatric vaccines market report are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

The Global Pediatric Vaccines Market is segmented:
1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies

    1. Executive Summary

    2. Pediatric Vaccines Market Characteristics

    3. Pediatric Vaccines Market Size And Growth

    3.1. Global Pediatric Vaccines Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Pediatric Vaccines Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Pediatric Vaccines Market Segmentation

    4.1. Global Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Monovalent

    Multivalent

    4.2. Global Pediatric Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Live Attenuated

    Inactivated

    Toxoid

    Conjugate

    Other Technologies

    5. Pediatric Vaccines Market Regional And Country Analysis

    5.1. Global Pediatric Vaccines Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Pediatric Vaccines Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Pediatric Vaccines Market  

    6.1. Asia-Pacific Pediatric Vaccines Market Overview  

    6.2. Asia-Pacific Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Pediatric Vaccines Market  

    7.1. China Pediatric Vaccines Market Overview  

    7.2. China Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Pediatric Vaccines Market  

    8.1. India Pediatric Vaccines Market Overview  

    8.2. India Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Pediatric Vaccines Market  

    9.1. Japan Pediatric Vaccines Market Overview  

    9.2. Japan Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Pediatric Vaccines Market  

    10.1. Australia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Pediatric Vaccines Market  

    11.1. Indonesia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Pediatric Vaccines Market  

    12.1. South Korea Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Pediatric Vaccines Market  

    13.1. Western Europe Pediatric Vaccines Market Overview

    13.2. Western Europe Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Pediatric Vaccines Market  

    14.1. UK Pediatric Vaccines Market Overview

    14.2. UK Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Pediatric Vaccines Market  

    15.1. Germany Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Pediatric Vaccines Market  

    16.3. France Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Pediatric Vaccines Market  

    17.1. Eastern Europe Pediatric Vaccines Market Overview

    17.2. Eastern Europe Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Pediatric Vaccines Market  

    18.1. Russia Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Pediatric Vaccines Market  

    19.1. North America Pediatric Vaccines Market Overview

    19.2. North America Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Pediatric Vaccines Market  

    20.1. USA Pediatric Vaccines Market Overview

    20.2. USA Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Pediatric Vaccines Market  

    21.1. South America Pediatric Vaccines Market Overview

    21.2. South America Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Pediatric Vaccines Market  

    22.1. Brazil Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Pediatric Vaccines Market  

    23.1. Middle East Pediatric Vaccines Market Overview

    23.2. Middle East Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Pediatric Vaccines Market  

    24.1. Africa Pediatric Vaccines Market Overview

    24.2. Africa Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Pediatric Vaccines Market Competitive Landscape And Company Profiles

    25.1. Pediatric Vaccines Market Competitive Landscape

    25.2. Pediatric Vaccines Market Company Profiles

    25.2.1. GlaxoSmithKline plc

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Pfizer Inc.

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Sanofi S.A.

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. Merck & Co., Inc.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Indian Immunologicals Limited

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Pediatric Vaccines Market

    27. Pediatric Vaccines Market Trends And Strategies

    28. Pediatric Vaccines Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Pediatric Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Pediatric Vaccines Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Pediatric Vaccines Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Asia-Pacific, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: China, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: India, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Japan, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Australia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: Indonesia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: South Korea, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Western Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: UK, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Germany, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: France, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Eastern Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Russia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: North America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: USA, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: South America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Brazil, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Middle East, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Africa, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: GlaxoSmithKline plc Financial Performance
  • Table 27: Pfizer Inc. Financial Performance
  • Table 28: Sanofi S.A. Financial Performance
  • Table 29: Merck & Co., Inc. Financial Performance
  • Table 30: Indian Immunologicals Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Pediatric Vaccines Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Pediatric Vaccines Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Pediatric Vaccines Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Asia-Pacific, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: China, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: India, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Japan, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Australia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: Indonesia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: South Korea, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Western Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: UK, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Germany, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: France, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Eastern Europe, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Russia, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: North America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: USA, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: South America, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Brazil, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Middle East, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Africa, Pediatric Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: GlaxoSmithKline plc Financial Performance
  • Figure 27: Pfizer Inc. Financial Performance
  • Figure 28: Sanofi S.A. Financial Performance
  • Figure 29: Merck & Co., Inc. Financial Performance
  • Figure 30: Indian Immunologicals Limited Financial Performance
New Drug Innovations In The Pharmaceuticals Market
Antithrombotic Drugs Are Being Used To Prevent Various Disorders
Increasing Rate Of The Elder Population Is Driving The Ophthalmology Drugs Market
Innovations In The Diabetes Therapies Market
Allergan plc- One Of The Largest Companies In The Global Drugs For Benign Prostatic Hypertrophy Market
Innovation And Development Of Combination Drugs To Enhance Growth Of The Ovarian Cancer Drugs Market
The Global Prostate Cancer Drugs Market Will Reach Around $10 By 2022
Antivirals Are The Largest And Fastest Growing Segment Of The Anti-Infective Drugs Market
Oncology Drugs Market - By Type (Blood Cancer, Breast Cancer, Lung Cancer, Prostate cancer, Colorectal Cancer, Cervical cancer, Kidney cancer, Gastric Cancer, Brain Tumor, Skin Cancer, Ovarian Cancer, Bladder Cancer, Pancreatic Cancer, Thyroid cancer, Others), By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy, Hormonal Therapy), By Distribution Channel (Retail Pharmacies/Drug Stores, Hospital Pharmacies, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded, Generic), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
CAR-T Therapy Market - By Target Antigen (CD19 Therapy, CD22 Therapy, BCMA Therapy, Others), By Application (Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Others), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Dry Eye Medication Market - By Type (Aqueous Dry Eye Syndrome, Evaporative Dry Eye Syndrome), By End-User (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies), By Product Type (Liquid Drops, Gel, Liquid Wipes, Eye Ointment), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Coronavirus (COVID-19) Current Therapy Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Drug Associated APIs Market Global Report 2020: COVID 19 Growth And Change
View Report
COVID19 Vaccine & Therapeutics Clinical Trial Analysis 2020
View Report
COVID19 Vaccine And Therapeutics Pipeline Analysis 2020
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)